FDA approves fenofibric acid for lipid target controls – Lower LDL, Increase HDL

Can’t get your LDL down, even with statins, one more drug to the rescue if needed, and can be taken with or without statin use and it should also raise the HDL, but there’s nothing related to prevent heart disease. BD

The FDA approved the new drug application of a new formulation of fenofibric acid — the first and only fibrate indicated for use in combination with a statin, according to a press release.

Fenofibric acid (Trilipix, Abbott) is manufactured as delayed-release 45-mg and 135-mg capsules and is intended to reduce both triglycerides and LDL and to raise HDL. However, fenofibric acid has not been shown to prevent heart disease or to prevent MI.

According to a manufacturer’s medication guide, fenofibric acid can be used in conjunction with atorvastatin (Lipitor, Caduet; Pfizer), fluvastatin (Lescol, Novartis), lovastatin (Altoprev, Mevacor, Advicor; Abbott), pravastatin (Pravachol, Bristol-Myers Squibb), rosuvastatin (Crestor, AstraZeneca) and simvastatin (Zocor, Simcor, Vytorin; Merck).

FDA approves fenofibric acid for lipid target controls